ArticleMedicine2026

Lipid-lowering drugs and essential hemorrhagic thrombocythemia's risk: A drug-target Mendelian randomization study.

Peng Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.